Volume 34, Issue 10 (January 2023)                   Studies in Medical Sciences 2023, 34(10): 598-607 | Back to browse issues page

Ethics code: IR.UMSU.REC.1400.409


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moulani S, Rasouli J, Asghari R, Alinejad V. THE RELATIONSHIP BETWEEN DEMOGRAPHIC CHARACTERISTICS AND UNDERLYING DISEASES WITH THE DISCHARGE STATUS OF COVID-19 PATIENTS IN THE INTENSIVE CARE UNIT. Studies in Medical Sciences 2023; 34 (10) :598-607
URL: http://umj.umsu.ac.ir/article-1-6088-en.html
Assistant Professor of Epidemiology, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , rsljvd@yahoo.com
Abstract:   (1070 Views)
Background & Aim: COVID-19 is an infectious disease that emerged as a pandemic in a short period. Pandemics are accompanied by high transmission rates and significant mortality. From a medical perspective, during all pandemics, the examination of individuals at risk due to chronic drug use or the presence of any underlying disease is crucial. The aim of this analytical-descriptive study was to investigate the relationship between demographic characteristics and underlying diseases with the discharge status of the patients with COVID-19 in the Intensive Care Unit.
Materials & Methods: In this study, the records of 430 patients with confirmed positive PCR tests, who were hospitalized in the Intensive Care Unit of Imam Khomeini Hospital from March 2020 to March 2021were included using a census method. Incomplete or inaccessible records were excluded. Demographic data (gender, age, marital status, etc.) and the history of underlying diseases (blood pressure, diabetes, heart conditions, etc.) were extracted from the records. The data were analyzed using descriptive statistics and hypothesis testing (t-test, chi-square) in SPSS software version 22.
Results: Out of 430 affected patients, 257 individuals (59.8%) were male, and 173 individuals (40.2%) were female. Among the deceased, 173 individuals (63.8%) were male, and 98 individuals (36.2%) were female, and this relationship was statistically significant (P=0.016). Furthermore, the association between hypertension and diabetes with mortality was found to be statistically significant based on the test results (P<0.001).
Discussion: The present study demonstrated that being male, as well as having hypertension and diabetes, are among the risk factors for both contracting and experiencing mortality due to COVID-19 infection.

 
Keywords: Covid-19, ICU, PCR Test
Full-Text [PDF 380 kb]   (507 Downloads)    
Type of Study: Research | Subject: Epidemiology

References
1. Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care 2020;24: 1-9. https: //doi.org/10.1186/s13054-020-02882-x [DOI:10.1186/s13054-020-02882-x] [PMID] []
2. Poorolajal J. Neglected major causes of death much deadlier than COVID-19. J Res Health Sci 2020;20(2): e00478. https: //doi.org/10.34172/jrhs.2020.13 [DOI:10.34172/jrhs.2020.13] [PMID] []
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11): 1061-9. https: //doi.org/10.1001/jama.2020.1585 [DOI:10.1001/jama.2020.1585] [PMID] []
4. Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8(5): 506-17. https: //doi.org/10.1016/S2213-2600(20)30161-2 [DOI:10.1016/S2213-2600(20)30161-2] [PMID]
5. Mirmohammadkhani M, Paknazar F, Rashidy-pour A. Evaluation of the epidemiological pattern of COVID-19 applying basic reproduction number: An educational review article. Koomesh 2020;22(3): 273-9. https: //doi.org/10.29252/koomesh.22.3.373 [DOI:10.29252/koomesh.22.3.373]
6. Panoutsopoulos AA. Conjunctivitis as a sentinel of SARS-CoV-2 infection: A need of revision for mild symptoms. SN Compr Clin Med 2020;2(7): 859-64. https: //doi.org/10.1007/s42399-020-00360-7 [DOI:10.1007/s42399-020-00360-7] [PMID] []
7. Team E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC weekly 2020 2;2(8): 113. https: //doi.org/10.46234/ccdcw2020.032 [DOI:10.46234/ccdcw2020.032]
8. Lee HW, Yoon SY, Lee JK, Park TY, Kim DK, Chung HS, et al. Clinical implication and risk factor of pneumonia development in mild coronavirus disease 2019 patients. Korean J Intern Med 2021;36(1): 1-10. https: //doi.org/10.3904/kjim.1990.5.1.1 [DOI:10.3904/kjim.2020.329] [PMID] []
9. Giraud R, Bendjelid K. COVID-19 pandemic: A new path to intensive care medicine distinction? Anaesth Crit Care Pain Med 2020;39(5): 545-6. https: //doi.org/10.1016/j.accpm.2020.07.010 [DOI:10.1016/j.accpm.2020.07.010] [PMID] []
10. National Institutes of Health (US) COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health; 2021 Apr. [URL]
11. Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL. Adult ICU triage during the Coronavirus disease 2019 pandemic: Who will live and who will die? Recommendations to improve survival. Crit Care Med 2020. https: //doi.org/10.1097/CCM.0000000000004410 [DOI:10.1097/CCM.0000000000004410] [PMID] []
12. Li J, Tian A, Yang D, Zhang M, Chen L, Wen J, et al. Celiac disease and the susceptibility of COVID-19 and the risk of severe COVID-19: A Mendelian randomization study. Clin Transl Gastroenterol 2022;13(5): e00480. https: //doi.org/10.14309/ctg.0000000000000480 [DOI:10.14309/ctg.0000000000000480] [PMID] []
13. Pande D, Kochhar A, Saini S, Ganapathy U, Gogia AR. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian J Palliat Care 2020;26(Suppl 1): S36-9. https: //doi.org/10.4103/IJPC.IJPC_146_20 [DOI:10.4103/IJPC.IJPC_146_20] [PMID] []
14. Calmes D, Graff S, Maes N, Frix AN, Thys M, Bonhomme O, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract 2021;9(1): 160-9. https: //doi.org/10.1016/j.jaip.2020.09.044 [DOI:10.1016/j.jaip.2020.09.044] [PMID] []
15. Halim AA, Alsayed B, Embarak S, Yaseen T, Dabbous S. Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients. Egypt J Chest Dis Tuberc 2016;65(1): 81-7. https: //doi.org/10.1016/j.ejcdt.2015.11.011 [DOI:10.1016/j.ejcdt.2015.11.011] [PMID] []
16. Jha M, Tak ML, Gupta R, Sharma P, Rajpurohit V, Mathur P, et al. Relationship of anemia with COVID-19 deaths: A retrospective cross-sectional study. J Anaesthesiol Clin Pharmacol 2022;38(Suppl 1): S115-9. https: //doi.org/10.4103/joacp.joacp_63_22 [DOI:10.4103/joacp.joacp_63_22] [PMID] []
17. Sevim M, Alkiş O, Kartal İG, Coşer Ş, Akman H, Aras B. Impact of COVID-19 on the progression of benign prostatic hyperplasia and aggravation of related symptoms: A prospective study. Prostate 2023;83(1): 82-6. https: //doi.org/10.1002/pros.24439 [DOI:10.1002/pros.24439] [PMID] []
18. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, et al. Clinical features and outcomes of ICU patients with COVID-19 infection in Tehran, Iran: A single-centered retrospective cohort study. Tanaffos 2020;19(4): 300-11. [PMID]
19. Cao J, Tu WT, Cheng W, Yu L, Liu K, Hu X, et al. Clinical Features and Short-term Outcomes of 102 Patients wit Coronavirus Disease. Clin Infec Dis 2019;71(15): 757. https: //doi.org/10.1093/cid/ciaa243 [DOI:10.1093/cid/ciaa243] [PMID] []
20. Ronderos D, Omar AMS, Abbas H, Makker J, Baiomi A, Sun H, et al. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases 2021;9(29): 8749-62. https: //doi.org/10.12998/wjcc.v9.i29.8749 [DOI:10.12998/wjcc.v9.i29.8749] [PMID] []
21. Wu B, Zhou JH, Wang WX, Yang HL, Xia M, Zhang BH, et al. Association analysis of hyperlipidemia with the 28-day all-cause mortality of COVID-19 in hospitalized patients. Chin Med Sci J 2021;36(1): 17-26. [Google Scholar]
22. Benoit JL, Benoit SW, de Oliveira MHS, Lippi G, Henry BM. Anemia and COVID-19: A prospective perspective. J Med Virol 2021;93(2): 708-11. https: //doi.org/10.1002/jmv.26530 [DOI:10.1002/jmv.26530] [PMID] []
23. Atmaca A, Demirci I, Haymana C, Tasci I, Sahin I, Cakal E, et al. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporos Int 2022;33(1): 273-82. https: //doi.org/10.1007/s00198-021-06067-2 [DOI:10.1007/s00198-021-06067-2] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Studies in Medical Sciences

Designed & Developed by : Yektaweb